Skip to main content
. 2022 Jan 19;13:385. doi: 10.1038/s41467-022-28020-5

Fig. 3. Genes’ proportions of cancer cell-derived expression in tumors.

Fig. 3

a For each cancer type, density of genes’ percent of transcripts attributed to cancer cells. b For all genes in all cancer types, estimated percent of transcripts attributed to cancer cells. c Averaged across all non-immune tumors, genes’ mean expression and percent of transcripts attributed to cancer cells. Panels show gene lists from CIBERSORT, EPIC, MCP-counter, quanTIseq, Timer, xCELL, Danaher (2017), and SafeTME, the tumor-immune deconvolution cell profile matrix developed here. Source data are provided as a Source Data file.